AARON J DIERINGER

Allopathic & Osteopathic Physicians|Family Medicine RENO, NV NPI 1750775193

General Payments — all program years on this page

$999.34

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 17
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $968.39 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Long term medical supply or device loan $797.608
Food and Beverage $170.798

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $30.951
2024 $968.3916

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078398052 Janssen Biotech, Inc. $21.54 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078398918 Janssen Biotech, Inc. $23.87 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086952633 Novartis Pharmaceuticals Corporation $99.70 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086952639 Novartis Pharmaceuticals Corporation $99.70 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086952649 Novartis Pharmaceuticals Corporation $99.70 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086952653 Novartis Pharmaceuticals Corporation $99.70 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086952657 Novartis Pharmaceuticals Corporation $99.70 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086952661 Novartis Pharmaceuticals Corporation $99.70 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086952665 Novartis Pharmaceuticals Corporation $99.70 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086952671 Novartis Pharmaceuticals Corporation $99.70 12/10/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1104506220 AstraZeneca Pharmaceuticals LP $23.64 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104551466 AstraZeneca Pharmaceuticals LP $20.48 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105726395 AstraZeneca Pharmaceuticals LP $24.14 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136000961 Lilly USA, LLC $15.68 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144956535 Takeda Pharmaceuticals U.S.A., Inc. $19.59 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144956537 Takeda Pharmaceuticals U.S.A., Inc. $21.85 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.